Blog
RSS FeedPosted by Michael Wonder on 26 Feb 2018
NHS could claw back £502m if Lyrica ruling upheld, study finds
26 February 2018 - The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin ...
Posted by Michael Wonder on 20 Dec 2017
'Drugs are too expensive for the NHS – and people are paying with their lives’
20 December 2017 - Don’t blame the NHS for denying vital medication, say members of a new activist group, Just Treatment. ...
Posted by Michael Wonder on 21 Nov 2017
Is the NHS being taken for a ride on drug prices? We need to know
21 November 2017 - The competition watchdog is investigating, but we need a wider inquiry into pharmaceutical firms’ practices. ...
Posted by Michael Wonder on 20 Nov 2017
Bureaucracy and duplication: the reality of the PPRS
20 November 2017 - In the fourth in her series of five articles looking at the objectives of the PPRS, ...
Posted by Michael Wonder on 12 Nov 2017
NHS England, Roche come to agreement on Perjeta
10 November 2017 - NHS England and Roche have agreed a confidential commercial agreement on the price of Perjeta for ...
Posted by Michael Wonder on 05 Oct 2017
ABPI update on application for judicial review
4 October 2017 - The ABPI have issued a statement regarding its application for judicial review versus NICE. ...
Posted by Michael Wonder on 30 Sep 2017
Improved access? The reality of the PPRS
29 September 2017 - In the third in her series of five articles, Leela Barham considers the extent to which ...
Posted by Michael Wonder on 12 Sep 2017
War on drugs: big pharma fights NHS bill curbs
10 September 2017 - With NHS budgets under pressure and medicine prices inexorably going up, something had to give. ...
Posted by Michael Wonder on 27 Aug 2017
Breast cancer drug Perjeta at risk in price wrangle
27 August 2017 - Thousands of women with advanced breast cancer could be denied a drug therapy that can extend ...
Posted by Michael Wonder on 17 Jul 2017
How the NHS became embroiled in a global drugs price clash
15 July 2017 - Multinational drug firms were never going to look good taking the NHS to court. ...
Posted by Michael Wonder on 07 Jun 2017
New UK law to control generic drug prices – implications for pharma
7 June 2017 - New UK regulation seeks to clarify and extend the Government’s powers to regulate the cost of medicines ...
Posted by Michael Wonder on 23 May 2017
US pharma giant Merck & Co. accused of blocking cheaper arthritis drugs for the NHS
23 May 2017 - The US pharmaceuticals giant Merck & Co is accused of abusing its dominance of the market ...
Posted by Michael Wonder on 10 May 2017
Cancer drug pricing: the truth and the rhetoric
9 May 2017 - Richard Torbett from the Association of the British Pharmaceutical Industry pens a letter to the Financial ...
Posted by Michael Wonder on 03 May 2017
Law finally passed to ban medicine price hiking by greedy drug firms
3 May 2017 - New legislation which is set to ban greedy drugs firms from extracting hundreds of millions of ...
Posted by Michael Wonder on 14 Apr 2017
Pharma giant Aspen accused of withholding drugs to force up prices
14 April 2017 - Staff at one of the world’s leading drug companies discussed destroying supplies of lifesaving cancer medicines ...